APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tenofovir Disoproxil Fumarate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tenofovir Disoproxil Fumarate Market Analysis and Forecast 2026-2032

Report ID 173874680223 December 2025213 pages

Choose your research edition.

Industry ResearchTenofovir Disoproxil Fumarate Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Tenofovir Disoproxil Fumarate Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Tenofovir Disoproxil Fumarate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tenofovir Disoproxil Fumarate Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Tenofovir Disoproxil Fumarate Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Tenofovir Disoproxil Fumarate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Tenofovir Disoproxil Fumarate's global sales reached XX (w pcs) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Abbott as the global sales leader, a title it has maintained for several consecutive years. Notably, Abbott's performance in primary markets is also remarkable. In the Chinese market, sales were XX (w pcs), a change of XX% from the previous year. In Europe, sales were XX (w pcs), showing a year-on-year of XX%. In the US, sales were XX (w pcs), a year-on-year change of XX%.

The major global manufacturers in the Tenofovir Disoproxil Fumarate market include Abbott, Qilu Pharmaceutical, Mylan Pharmaceuticals, Glaxo SmithKline, Chengdu Brilliant Pharmaceutical, Zydus Cadila, Wockhardt Ltd, Torrent Pharmaceuticals and Natco Pharma, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Tenofovir Disoproxil Fumarate production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Tenofovir Disoproxil Fumarate by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Tenofovir Disoproxil Fumarate, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tenofovir Disoproxil Fumarate, also provides the consumption of main regions and countries. Of the upcoming market potential for Tenofovir Disoproxil Fumarate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tenofovir Disoproxil Fumarate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tenofovir Disoproxil Fumarate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tenofovir Disoproxil Fumarate sales, projected growth trends, production technology, application and end-user industry.

Tenofovir Disoproxil Fumarate Segment by Company

Abbott

Qilu Pharmaceutical

Mylan Pharmaceuticals

Glaxo SmithKline

Chengdu Brilliant Pharmaceutical

Zydus Cadila

Wockhardt Ltd

Torrent Pharmaceuticals

Natco Pharma

Hetero Drugs

Gilead PHARMACARE

Emcure Pharmaceuticals

Dr Reddy's Laboratories

Cipla

CHIA TAI TIANQING (CTTQ) Pharmaceutical

Anhui Biochem Pharmaceutical

Tenofovir Disoproxil Fumarate Segment by Type

30 Pcs/Box

10 Pcs/Box

Tenofovir Disoproxil Fumarate Segment by Application

HIV-1 Infection

Chronic Hepatitis

Others

Tenofovir Disoproxil Fumarate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenofovir Disoproxil Fumarate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tenofovir Disoproxil Fumarate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenofovir Disoproxil Fumarate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Tenofovir Disoproxil Fumarate production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Tenofovir Disoproxil Fumarate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Tenofovir Disoproxil Fumarate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tenofovir Disoproxil Fumarate sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tenofovir Disoproxil Fumarate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 30 Pcs/Box Major Manufacturers Table 3. 10 Pcs/Box Major Manufacturers Table 4. Global Tenofovir Disoproxil Fumarate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. HIV-1 Infection Major Manufacturers Table 6. Chronic Hepatitis Major Manufacturers Table 7. Others Major Manufacturers Table 8. Tenofovir Disoproxil Fumarate Industry Trends Table 9. Tenofovir Disoproxil Fumarate Industry Drivers Table 10. Tenofovir Disoproxil Fumarate Industry Opportunities and Challenges Table 11. Tenofovir Disoproxil Fumarate Industry Restraints Table 12. Global Tenofovir Disoproxil Fumarate Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (w pcs) Table 13. Global Tenofovir Disoproxil Fumarate Production by Region (2021-2026) & (w pcs) Table 14. Global Tenofovir Disoproxil Fumarate Production by Region (2027-2032) & (w pcs) Table 15. Global Tenofovir Disoproxil Fumarate Production Market Share by Region (2021-2026) Table 16. Global Tenofovir Disoproxil Fumarate Production Market Share by Region (2027-2032) Table 17. Global Tenofovir Disoproxil Fumarate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Tenofovir Disoproxil Fumarate Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Tenofovir Disoproxil Fumarate Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2021-2026) Table 21. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2027-2032) Table 22. Global Tenofovir Disoproxil Fumarate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (w pcs) Table 23. Global Tenofovir Disoproxil Fumarate Sales by Region (2021-2026) & (w pcs) Table 24. Global Tenofovir Disoproxil Fumarate Sales by Region (2027-2032) & (w pcs) Table 25. Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2021-2026) Table 26. Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2027-2032) Table 27. Global Tenofovir Disoproxil Fumarate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Tenofovir Disoproxil Fumarate Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Tenofovir Disoproxil Fumarate Sales Market Share by Manufacturers (2021-2026) Table 31. Global Tenofovir Disoproxil Fumarate Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 32. Global Tenofovir Disoproxil Fumarate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Tenofovir Disoproxil Fumarate Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Tenofovir Disoproxil Fumarate Manufacturers, Product Type & Application Table 35. Global Tenofovir Disoproxil Fumarate Manufacturers Commercialization Time Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Tenofovir Disoproxil Fumarate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 38. Global Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Tenofovir Disoproxil Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2021-2026) Table 41. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2027-2032) Table 42. Global Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (w pcs) Table 43. Global Tenofovir Disoproxil Fumarate Sales by Type (2027-2032) & (w pcs) Table 44. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2021-2026) Table 45. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2027-2032) Table 46. Global Tenofovir Disoproxil Fumarate Price by Type (2021-2026) & (US$/pcs) Table 47. Global Tenofovir Disoproxil Fumarate Price by Type (2027-2032) & (US$/pcs) Table 48. Global Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Tenofovir Disoproxil Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2021-2026) Table 51. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2027-2032) Table 52. Global Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (w pcs) Table 53. Global Tenofovir Disoproxil Fumarate Sales by Application (2027-2032) & (w pcs) Table 54. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2021-2026) Table 55. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2027-2032) Table 56. Global Tenofovir Disoproxil Fumarate Price by Application (2021-2026) & (US$/pcs) Table 57. Global Tenofovir Disoproxil Fumarate Price by Application (2027-2032) & (US$/pcs) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Abbott Tenofovir Disoproxil Fumarate Product Portfolio Table 62. Abbott Recent Development Table 63. Qilu Pharmaceutical Company Information Table 64. Qilu Pharmaceutical Business Overview Table 65. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 67. Qilu Pharmaceutical Recent Development Table 68. Mylan Pharmaceuticals Company Information Table 69. Mylan Pharmaceuticals Business Overview Table 70. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio Table 72. Mylan Pharmaceuticals Recent Development Table 73. Glaxo SmithKline Company Information Table 74. Glaxo SmithKline Business Overview Table 75. Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. Glaxo SmithKline Tenofovir Disoproxil Fumarate Product Portfolio Table 77. Glaxo SmithKline Recent Development Table 78. Chengdu Brilliant Pharmaceutical Company Information Table 79. Chengdu Brilliant Pharmaceutical Business Overview Table 80. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 82. Chengdu Brilliant Pharmaceutical Recent Development Table 83. Zydus Cadila Company Information Table 84. Zydus Cadila Business Overview Table 85. Zydus Cadila Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 86. Zydus Cadila Tenofovir Disoproxil Fumarate Product Portfolio Table 87. Zydus Cadila Recent Development Table 88. Wockhardt Ltd Company Information Table 89. Wockhardt Ltd Business Overview Table 90. Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 91. Wockhardt Ltd Tenofovir Disoproxil Fumarate Product Portfolio Table 92. Wockhardt Ltd Recent Development Table 93. Torrent Pharmaceuticals Company Information Table 94. Torrent Pharmaceuticals Business Overview Table 95. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 96. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio Table 97. Torrent Pharmaceuticals Recent Development Table 98. Natco Pharma Company Information Table 99. Natco Pharma Business Overview Table 100. Natco Pharma Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 101. Natco Pharma Tenofovir Disoproxil Fumarate Product Portfolio Table 102. Natco Pharma Recent Development Table 103. Hetero Drugs Company Information Table 104. Hetero Drugs Business Overview Table 105. Hetero Drugs Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 106. Hetero Drugs Tenofovir Disoproxil Fumarate Product Portfolio Table 107. Hetero Drugs Recent Development Table 108. Gilead PHARMACARE Company Information Table 109. Gilead PHARMACARE Business Overview Table 110. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 111. Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product Portfolio Table 112. Gilead PHARMACARE Recent Development Table 113. Emcure Pharmaceuticals Company Information Table 114. Emcure Pharmaceuticals Business Overview Table 115. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 116. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio Table 117. Emcure Pharmaceuticals Recent Development Table 118. Dr Reddy's Laboratories Company Information Table 119. Dr Reddy's Laboratories Business Overview Table 120. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 121. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product Portfolio Table 122. Dr Reddy's Laboratories Recent Development Table 123. Cipla Company Information Table 124. Cipla Business Overview Table 125. Cipla Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 126. Cipla Tenofovir Disoproxil Fumarate Product Portfolio Table 127. Cipla Recent Development Table 128. CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Information Table 129. CHIA TAI TIANQING (CTTQ) Pharmaceutical Business Overview Table 130. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 131. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 132. CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development Table 133. Anhui Biochem Pharmaceutical Company Information Table 134. Anhui Biochem Pharmaceutical Business Overview Table 135. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales (w pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 136. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio Table 137. Anhui Biochem Pharmaceutical Recent Development Table 138. North America Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 139. North America Tenofovir Disoproxil Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 140. North America Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (w pcs) Table 141. North America Tenofovir Disoproxil Fumarate Sales by Type (2027-2032) & (w pcs) Table 142. North America Tenofovir Disoproxil Fumarate Sales Price by Type (2021-2026) & (US$/pcs) Table 143. North America Tenofovir Disoproxil Fumarate Sales Price by Type (2027-2032) & (US$/pcs) Table 144. North America Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 145. North America Tenofovir Disoproxil Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 146. North America Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (w pcs) Table 147. North America Tenofovir Disoproxil Fumarate Sales by Application (2027-2032) & (w pcs) Table 148. North America Tenofovir Disoproxil Fumarate Sales Price by Application (2021-2026) & (US$/pcs) Table 149. North America Tenofovir Disoproxil Fumarate Sales Price by Application (2027-2032) & (US$/pcs) Table 150. North America Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. North America Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 152. North America Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 153. North America Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032) & (w pcs) Table 154. North America Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (w pcs) Table 155. North America Tenofovir Disoproxil Fumarate Sales by Country (2027-2032) & (w pcs) Table 156. North America Tenofovir Disoproxil Fumarate Sales Price by Country (2021-2026) & (US$/pcs) Table 157. North America Tenofovir Disoproxil Fumarate Sales Price by Country (2027-2032) & (US$/pcs) Table 158. United States Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 159. Canada Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 160. Mexico Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 161. Europe Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 162. Europe Tenofovir Disoproxil Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 163. Europe Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (w pcs) Table 164. Europe Tenofovir Disoproxil Fumarate Sales by Type (2027-2032) & (w pcs) Table 165. Europe Tenofovir Disoproxil Fumarate Sales Price by Type (2021-2026) & (US$/pcs) Table 166. Europe Tenofovir Disoproxil Fumarate Sales Price by Type (2027-2032) & (US$/pcs) Table 167. Europe Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 168. Europe Tenofovir Disoproxil Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 169. Europe Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (w pcs) Table 170. Europe Tenofovir Disoproxil Fumarate Sales by Application (2027-2032) & (w pcs) Table 171. Europe Tenofovir Disoproxil Fumarate Sales Price by Application (2021-2026) & (US$/pcs) Table 172. Europe Tenofovir Disoproxil Fumarate Sales Price by Application (2027-2032) & (US$/pcs) Table 173. Europe Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Europe Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Europe Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Europe Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032) & (w pcs) Table 177. Europe Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (w pcs) Table 178. Europe Tenofovir Disoproxil Fumarate Sales by Country (2027-2032) & (w pcs) Table 179. Europe Tenofovir Disoproxil Fumarate Sales Price by Country (2021-2026) & (US$/pcs) Table 180. Europe Tenofovir Disoproxil Fumarate Sales Price by Country (2027-2032) & (US$/pcs) Table 181. Germany Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 182. France Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 183. U.K. Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 184. Italy Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 185. Russia Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 186. Spain Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 187. Netherlands Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 188. Switzerland Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 189. Sweden Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 190. Poland Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 191. China Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 192. China Tenofovir Disoproxil Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 193. China Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (w pcs) Table 194. China Tenofovir Disoproxil Fumarate Sales by Type (2027-2032) & (w pcs) Table 195. China Tenofovir Disoproxil Fumarate Sales Price by Type (2021-2026) & (US$/pcs) Table 196. China Tenofovir Disoproxil Fumarate Sales Price by Type (2027-2032) & (US$/pcs) Table 197. China Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 198. China Tenofovir Disoproxil Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 199. China Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (w pcs) Table 200. China Tenofovir Disoproxil Fumarate Sales by Application (2027-2032) & (w pcs) Table 201. China Tenofovir Disoproxil Fumarate Sales Price by Application (2021-2026) & (US$/pcs) Table 202. China Tenofovir Disoproxil Fumarate Sales Price by Application (2027-2032) & (US$/pcs) Table 203. Asia Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Tenofovir Disoproxil Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (w pcs) Table 206. Asia Tenofovir Disoproxil Fumarate Sales by Type (2027-2032) & (w pcs) Table 207. Asia Tenofovir Disoproxil Fumarate Sales Price by Type (2021-2026) & (US$/pcs) Table 208. Asia Tenofovir Disoproxil Fumarate Sales Price by Type (2027-2032) & (US$/pcs) Table 209. Asia Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Tenofovir Disoproxil Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (w pcs) Table 212. Asia Tenofovir Disoproxil Fumarate Sales by Application (2027-2032) & (w pcs) Table 213. Asia Tenofovir Disoproxil Fumarate Sales Price by Application (2021-2026) & (US$/pcs) Table 214. Asia Tenofovir Disoproxil Fumarate Sales Price by Application (2027-2032) & (US$/pcs) Table 215. Asia Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032) & (w pcs) Table 219. Asia Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (w pcs) Table 220. Asia Tenofovir Disoproxil Fumarate Sales by Country (2027-2032) & (w pcs) Table 221. Asia Tenofovir Disoproxil Fumarate Sales Price by Country (2021-2026) & (US$/pcs) Table 222. Asia Tenofovir Disoproxil Fumarate Sales Price by Country (2027-2032) & (US$/pcs) Table 223. Japan Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 224. South Korea Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 225. India Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 226. Australia Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 227. Taiwan Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Tenofovir Disoproxil Fumarate Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Tenofovir Disoproxil Fumarate Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Tenofovir Disoproxil Fumarate Sales by Type (2021-2026) & (w pcs) Table 232. SAMEA Tenofovir Disoproxil Fumarate Sales by Type (2027-2032) & (w pcs) Table 233. SAMEA Tenofovir Disoproxil Fumarate Sales Price by Type (2021-2026) & (US$/pcs) Table 234. SAMEA Tenofovir Disoproxil Fumarate Sales Price by Type (2027-2032) & (US$/pcs) Table 235. SAMEA Tenofovir Disoproxil Fumarate Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Tenofovir Disoproxil Fumarate Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Tenofovir Disoproxil Fumarate Sales by Application (2021-2026) & (w pcs) Table 238. SAMEA Tenofovir Disoproxil Fumarate Sales by Application (2027-2032) & (w pcs) Table 239. SAMEA Tenofovir Disoproxil Fumarate Sales Price by Application (2021-2026) & (US$/pcs) Table 240. SAMEA Tenofovir Disoproxil Fumarate Sales Price by Application (2027-2032) & (US$/pcs) Table 241. SAMEA Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032) & (w pcs) Table 245. SAMEA Tenofovir Disoproxil Fumarate Sales by Country (2021-2026) & (w pcs) Table 246. SAMEA Tenofovir Disoproxil Fumarate Sales by Country (2027-2032) & (w pcs) Table 247. SAMEA Tenofovir Disoproxil Fumarate Sales Price by Country (2021-2026) & (US$/pcs) Table 248. SAMEA Tenofovir Disoproxil Fumarate Sales Price by Country (2027-2032) & (US$/pcs) Table 249. Brazil Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 250. Argentina Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 251. Chile Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 252. Colombia Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 253. Peru Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 255. Israel Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 256. UAE Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 257. Turkey Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 258. Iran Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 259. Egypt Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Tenofovir Disoproxil Fumarate Distributors List Table 263. Tenofovir Disoproxil Fumarate Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Tenofovir Disoproxil Fumarate Product Image Figure 2. Global Tenofovir Disoproxil Fumarate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tenofovir Disoproxil Fumarate Market Size Share 2021 VS 2025 VS 2032 Figure . 30 Pcs/Box Image Figure 1. 10 Pcs/Box Image Figure 2. Global Tenofovir Disoproxil Fumarate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tenofovir Disoproxil Fumarate Market Size Share 2021 VS 2025 VS 2032 Figure 4. HIV-1 Infection Image Figure 5. Chronic Hepatitis Image Figure 6. Others Image Figure 7. Global Tenofovir Disoproxil Fumarate Capacity, Capacity Utilization (2021-2032) & (w pcs) Figure 8. Global Tenofovir Disoproxil Fumarate Production by Region: 2021 VS 2025 VS 2032 (w pcs) Figure 9. Global Tenofovir Disoproxil Fumarate Production Market Share by Region: 2025 Versus 2032 Figure 10. Global Tenofovir Disoproxil Fumarate Production Market Share by Region (2021-2032) Figure 11. North America Tenofovir Disoproxil Fumarate Production Growth Rate (2021-2032) & (w pcs) Figure 12. Europe Tenofovir Disoproxil Fumarate Production Growth Rate (2021-2032) & (w pcs) Figure 13. China Tenofovir Disoproxil Fumarate Production Growth Rate (2021-2032) & (w pcs) Figure 14. Japan Tenofovir Disoproxil Fumarate Production Growth Rate (2021-2032) & (w pcs) Figure 15. Global Tenofovir Disoproxil Fumarate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Tenofovir Disoproxil Fumarate Revenue (2021-2032) & (US$ Million) Figure 17. Global Tenofovir Disoproxil Fumarate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2021-2032) Figure 20. Global Tenofovir Disoproxil Fumarate Sales (2021-2032) & (w pcs) Figure 21. Global Tenofovir Disoproxil Fumarate Sales by Region: 2021 VS 2025 VS 2032 (w pcs) Figure 22. Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2021-2032) Figure 23. North America Tenofovir Disoproxil Fumarate Sales YoY (2021-2032) & (w pcs) Figure 24. Europe Tenofovir Disoproxil Fumarate Sales YoY (2021-2032) & (w pcs) Figure 25. China Tenofovir Disoproxil Fumarate Sales YoY (2021-2032) & (w pcs) Figure 26. Asia (Excluding China) Tenofovir Disoproxil Fumarate Sales YoY (2021-2032) & (w pcs) Figure 27. South America, Middle East and Africa Tenofovir Disoproxil Fumarate Sales YoY (2021-2032) & (w pcs) Figure 28. Global Tenofovir Disoproxil Fumarate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Tenofovir Disoproxil Fumarate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2021-2032) Figure 32. Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2021-2032) Figure 33. Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2021-2032) Figure 34. Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2021-2032) Figure 35. North America Tenofovir Disoproxil Fumarate Revenue Share by Type (2021-2032) Figure 36. North America Tenofovir Disoproxil Fumarate Sales Share by Type (2021-2032) Figure 37. North America Tenofovir Disoproxil Fumarate Revenue Share by Application (2021-2032) Figure 38. North America Tenofovir Disoproxil Fumarate Sales Share by Application (2021-2032) Figure 39. North America Tenofovir Disoproxil Fumarate Revenue Share by Country (2021-2032) Figure 40. North America Tenofovir Disoproxil Fumarate Sales Share by Country (2021-2032) Figure 41. Europe Tenofovir Disoproxil Fumarate Revenue Share by Type (2021-2032) Figure 42. Europe Tenofovir Disoproxil Fumarate Sales Share by Type (2021-2032) Figure 43. Europe Tenofovir Disoproxil Fumarate Revenue Share by Application (2021-2032) Figure 44. Europe Tenofovir Disoproxil Fumarate Sales Share by Application (2021-2032) Figure 45. Europe Tenofovir Disoproxil Fumarate Revenue Share by Country (2021-2032) Figure 46. Europe Tenofovir Disoproxil Fumarate Sales Share by Country (2021-2032) Figure 47. China Tenofovir Disoproxil Fumarate Revenue Share by Type (2021-2032) Figure 48. China Tenofovir Disoproxil Fumarate Sales Share by Type (2021-2032) Figure 49. China Tenofovir Disoproxil Fumarate Revenue Share by Application (2021-2032) Figure 50. China Tenofovir Disoproxil Fumarate Sales Share by Application (2021-2032) Figure 51. Asia Tenofovir Disoproxil Fumarate Revenue Share by Type (2021-2032) Figure 52. Asia Tenofovir Disoproxil Fumarate Sales Share by Type (2021-2032) Figure 53. Asia Tenofovir Disoproxil Fumarate Revenue Share by Application (2021-2032) Figure 54. Asia Tenofovir Disoproxil Fumarate Sales Share by Application (2021-2032) Figure 55. Asia Tenofovir Disoproxil Fumarate Revenue Share by Country (2021-2032) Figure 56. Asia Tenofovir Disoproxil Fumarate Sales Share by Country (2021-2032) Figure 57. SAMEA Tenofovir Disoproxil Fumarate Revenue Share by Type (2021-2032) Figure 58. SAMEA Tenofovir Disoproxil Fumarate Sales Share by Type (2021-2032) Figure 59. SAMEA Tenofovir Disoproxil Fumarate Revenue Share by Application (2021-2032) Figure 60. SAMEA Tenofovir Disoproxil Fumarate Sales Share by Application (2021-2032) Figure 61. SAMEA Tenofovir Disoproxil Fumarate Revenue Share by Country (2021-2032) Figure 62. SAMEA Tenofovir Disoproxil Fumarate Sales Share by Country (2021-2032) Figure 63. Tenofovir Disoproxil Fumarate Value Chain Figure 64. Manufacturing Cost Structure Figure 65. Tenofovir Disoproxil Fumarate Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • 30 Pcs/Box
  • 10 Pcs/Box
Applications
  • HIV-1 Infection
  • Chronic Hepatitis
  • Others
Companies covered
  • Abbott
  • Qilu Pharmaceutical
  • Mylan Pharmaceuticals
  • Glaxo SmithKline
  • Chengdu Brilliant Pharmaceutical
  • Zydus Cadila
  • Wockhardt Ltd
  • Torrent Pharmaceuticals
  • Natco Pharma
  • Hetero Drugs
  • Gilead PHARMACARE
  • Emcure Pharmaceuticals
  • Dr Reddy's Laboratories
  • Cipla
  • CHIA TAI TIANQING (CTTQ) Pharmaceutical
  • Anhui Biochem Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tenofovir Disoproxil Fumarate Market by Type
  3. 1.2.1 Global Tenofovir Disoproxil Fumarate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 30 Pcs/Box
  5. 1.2.3 10 Pcs/Box
  6. 1.3 Tenofovir Disoproxil Fumarate Market by Application
  7. 1.3.1 Global Tenofovir Disoproxil Fumarate Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 HIV-1 Infection
  9. 1.3.3 Chronic Hepatitis
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Tenofovir Disoproxil Fumarate Market Dynamics
  1. 2.1 Tenofovir Disoproxil Fumarate Industry Trends
  2. 2.2 Tenofovir Disoproxil Fumarate Industry Drivers
  3. 2.3 Tenofovir Disoproxil Fumarate Industry Opportunities and Challenges
  4. 2.4 Tenofovir Disoproxil Fumarate Industry Restraints
3 Global Tenofovir Disoproxil Fumarate Production Overview
  1. 3.1 Global Tenofovir Disoproxil Fumarate Production Capacity (2021-2032)
  2. 3.2 Global Tenofovir Disoproxil Fumarate Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Tenofovir Disoproxil Fumarate Production by Region
  4. 3.3.1 Global Tenofovir Disoproxil Fumarate Production by Region (2021-2026)
  5. 3.3.2 Global Tenofovir Disoproxil Fumarate Production by Region (2027-2032)
  6. 3.3.3 Global Tenofovir Disoproxil Fumarate Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Tenofovir Disoproxil Fumarate Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Tenofovir Disoproxil Fumarate Revenue by Region
  3. 4.2.1 Global Tenofovir Disoproxil Fumarate Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Tenofovir Disoproxil Fumarate Revenue by Region (2021-2026)
  5. 4.2.3 Global Tenofovir Disoproxil Fumarate Revenue by Region (2027-2032)
  6. 4.2.4 Global Tenofovir Disoproxil Fumarate Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Tenofovir Disoproxil Fumarate Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Tenofovir Disoproxil Fumarate Sales by Region
  9. 4.4.1 Global Tenofovir Disoproxil Fumarate Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Tenofovir Disoproxil Fumarate Sales by Region (2021-2026)
  11. 4.4.3 Global Tenofovir Disoproxil Fumarate Sales by Region (2027-2032)
  12. 4.4.4 Global Tenofovir Disoproxil Fumarate Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Tenofovir Disoproxil Fumarate Revenue by Manufacturers
  2. 5.1.1 Global Tenofovir Disoproxil Fumarate Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Tenofovir Disoproxil Fumarate Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Tenofovir Disoproxil Fumarate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Tenofovir Disoproxil Fumarate Sales by Manufacturers
  6. 5.2.1 Global Tenofovir Disoproxil Fumarate Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Tenofovir Disoproxil Fumarate Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Tenofovir Disoproxil Fumarate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Tenofovir Disoproxil Fumarate Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Tenofovir Disoproxil Fumarate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Tenofovir Disoproxil Fumarate Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Tenofovir Disoproxil Fumarate Manufacturers, Product Type & Application
  13. 5.7 Global Tenofovir Disoproxil Fumarate Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Tenofovir Disoproxil Fumarate Market CR5 and HHI
  16. 5.8.2 2025 Tenofovir Disoproxil Fumarate Tier 1, Tier 2, and Tier 3
6 Tenofovir Disoproxil Fumarate Market by Type
  1. 6.1 Global Tenofovir Disoproxil Fumarate Revenue by Type
  2. 6.1.1 Global Tenofovir Disoproxil Fumarate Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Tenofovir Disoproxil Fumarate Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Tenofovir Disoproxil Fumarate Sales by Type
  5. 6.2.1 Global Tenofovir Disoproxil Fumarate Sales by Type (2021-2032) & (w pcs)
  6. 6.2.2 Global Tenofovir Disoproxil Fumarate Sales Market Share by Type (2021-2032)
  7. 6.3 Global Tenofovir Disoproxil Fumarate Price by Type
7 Tenofovir Disoproxil Fumarate Market by Application
  1. 7.1 Global Tenofovir Disoproxil Fumarate Revenue by Application
  2. 7.1.1 Global Tenofovir Disoproxil Fumarate Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Tenofovir Disoproxil Fumarate Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Tenofovir Disoproxil Fumarate Sales by Application
  5. 7.2.1 Global Tenofovir Disoproxil Fumarate Sales by Application (2021-2032) & (w pcs)
  6. 7.2.2 Global Tenofovir Disoproxil Fumarate Sales Market Share by Application (2021-2032)
  7. 7.3 Global Tenofovir Disoproxil Fumarate Price by Application
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Tenofovir Disoproxil Fumarate Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Qilu Pharmaceutical
  8. 8.2.1 Qilu Pharmaceutical Company Information
  9. 8.2.2 Qilu Pharmaceutical Business Overview
  10. 8.2.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio
  12. 8.2.5 Qilu Pharmaceutical Recent Developments
  13. 8.3 Mylan Pharmaceuticals
  14. 8.3.1 Mylan Pharmaceuticals Company Information
  15. 8.3.2 Mylan Pharmaceuticals Business Overview
  16. 8.3.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio
  18. 8.3.5 Mylan Pharmaceuticals Recent Developments
  19. 8.4 Glaxo SmithKline
  20. 8.4.1 Glaxo SmithKline Company Information
  21. 8.4.2 Glaxo SmithKline Business Overview
  22. 8.4.3 Glaxo SmithKline Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Glaxo SmithKline Tenofovir Disoproxil Fumarate Product Portfolio
  24. 8.4.5 Glaxo SmithKline Recent Developments
  25. 8.5 Chengdu Brilliant Pharmaceutical
  26. 8.5.1 Chengdu Brilliant Pharmaceutical Company Information
  27. 8.5.2 Chengdu Brilliant Pharmaceutical Business Overview
  28. 8.5.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio
  30. 8.5.5 Chengdu Brilliant Pharmaceutical Recent Developments
  31. 8.6 Zydus Cadila
  32. 8.6.1 Zydus Cadila Company Information
  33. 8.6.2 Zydus Cadila Business Overview
  34. 8.6.3 Zydus Cadila Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Cadila Tenofovir Disoproxil Fumarate Product Portfolio
  36. 8.6.5 Zydus Cadila Recent Developments
  37. 8.7 Wockhardt Ltd
  38. 8.7.1 Wockhardt Ltd Company Information
  39. 8.7.2 Wockhardt Ltd Business Overview
  40. 8.7.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Wockhardt Ltd Tenofovir Disoproxil Fumarate Product Portfolio
  42. 8.7.5 Wockhardt Ltd Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Natco Pharma
  50. 8.9.1 Natco Pharma Company Information
  51. 8.9.2 Natco Pharma Business Overview
  52. 8.9.3 Natco Pharma Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Natco Pharma Tenofovir Disoproxil Fumarate Product Portfolio
  54. 8.9.5 Natco Pharma Recent Developments
  55. 8.10 Hetero Drugs
  56. 8.10.1 Hetero Drugs Company Information
  57. 8.10.2 Hetero Drugs Business Overview
  58. 8.10.3 Hetero Drugs Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 8.10.4 Hetero Drugs Tenofovir Disoproxil Fumarate Product Portfolio
  60. 8.10.5 Hetero Drugs Recent Developments
  61. 8.11 Gilead PHARMACARE
  62. 8.11.1 Gilead PHARMACARE Company Information
  63. 8.11.2 Gilead PHARMACARE Business Overview
  64. 8.11.3 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 8.11.4 Gilead PHARMACARE Tenofovir Disoproxil Fumarate Product Portfolio
  66. 8.11.5 Gilead PHARMACARE Recent Developments
  67. 8.12 Emcure Pharmaceuticals
  68. 8.12.1 Emcure Pharmaceuticals Company Information
  69. 8.12.2 Emcure Pharmaceuticals Business Overview
  70. 8.12.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 8.12.4 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate Product Portfolio
  72. 8.12.5 Emcure Pharmaceuticals Recent Developments
  73. 8.13 Dr Reddy's Laboratories
  74. 8.13.1 Dr Reddy's Laboratories Company Information
  75. 8.13.2 Dr Reddy's Laboratories Business Overview
  76. 8.13.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 8.13.4 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate Product Portfolio
  78. 8.13.5 Dr Reddy's Laboratories Recent Developments
  79. 8.14 Cipla
  80. 8.14.1 Cipla Company Information
  81. 8.14.2 Cipla Business Overview
  82. 8.14.3 Cipla Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 8.14.4 Cipla Tenofovir Disoproxil Fumarate Product Portfolio
  84. 8.14.5 Cipla Recent Developments
  85. 8.15 CHIA TAI TIANQING (CTTQ) Pharmaceutical
  86. 8.15.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Information
  87. 8.15.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Business Overview
  88. 8.15.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 8.15.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio
  90. 8.15.5 CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Developments
  91. 8.16 Anhui Biochem Pharmaceutical
  92. 8.16.1 Anhui Biochem Pharmaceutical Company Information
  93. 8.16.2 Anhui Biochem Pharmaceutical Business Overview
  94. 8.16.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 8.16.4 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate Product Portfolio
  96. 8.16.5 Anhui Biochem Pharmaceutical Recent Developments
9 North America
  1. 9.1 North America Tenofovir Disoproxil Fumarate Market Size by Type
  2. 9.1.1 North America Tenofovir Disoproxil Fumarate Revenue by Type (2021-2032)
  3. 9.1.2 North America Tenofovir Disoproxil Fumarate Sales by Type (2021-2032)
  4. 9.1.3 North America Tenofovir Disoproxil Fumarate Price by Type (2021-2032)
  5. 9.2 North America Tenofovir Disoproxil Fumarate Market Size by Application
  6. 9.2.1 North America Tenofovir Disoproxil Fumarate Revenue by Application (2021-2032)
  7. 9.2.2 North America Tenofovir Disoproxil Fumarate Sales by Application (2021-2032)
  8. 9.2.3 North America Tenofovir Disoproxil Fumarate Price by Application (2021-2032)
  9. 9.3 North America Tenofovir Disoproxil Fumarate Market Size by Country
  10. 9.3.1 North America Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Tenofovir Disoproxil Fumarate Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Tenofovir Disoproxil Fumarate Market Size by Type
  2. 10.1.1 Europe Tenofovir Disoproxil Fumarate Revenue by Type (2021-2032)
  3. 10.1.2 Europe Tenofovir Disoproxil Fumarate Sales by Type (2021-2032)
  4. 10.1.3 Europe Tenofovir Disoproxil Fumarate Price by Type (2021-2032)
  5. 10.2 Europe Tenofovir Disoproxil Fumarate Market Size by Application
  6. 10.2.1 Europe Tenofovir Disoproxil Fumarate Revenue by Application (2021-2032)
  7. 10.2.2 Europe Tenofovir Disoproxil Fumarate Sales by Application (2021-2032)
  8. 10.2.3 Europe Tenofovir Disoproxil Fumarate Price by Application (2021-2032)
  9. 10.3 Europe Tenofovir Disoproxil Fumarate Market Size by Country
  10. 10.3.1 Europe Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Tenofovir Disoproxil Fumarate Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Tenofovir Disoproxil Fumarate Market Size by Type
  2. 11.1.1 China Tenofovir Disoproxil Fumarate Revenue by Type (2021-2032)
  3. 11.1.2 China Tenofovir Disoproxil Fumarate Sales by Type (2021-2032)
  4. 11.1.3 China Tenofovir Disoproxil Fumarate Price by Type (2021-2032)
  5. 11.2 China Tenofovir Disoproxil Fumarate Market Size by Application
  6. 11.2.1 China Tenofovir Disoproxil Fumarate Revenue by Application (2021-2032)
  7. 11.2.2 China Tenofovir Disoproxil Fumarate Sales by Application (2021-2032)
  8. 11.2.3 China Tenofovir Disoproxil Fumarate Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Tenofovir Disoproxil Fumarate Market Size by Type
  2. 12.1.1 Asia Tenofovir Disoproxil Fumarate Revenue by Type (2021-2032)
  3. 12.1.2 Asia Tenofovir Disoproxil Fumarate Sales by Type (2021-2032)
  4. 12.1.3 Asia Tenofovir Disoproxil Fumarate Price by Type (2021-2032)
  5. 12.2 Asia Tenofovir Disoproxil Fumarate Market Size by Application
  6. 12.2.1 Asia Tenofovir Disoproxil Fumarate Revenue by Application (2021-2032)
  7. 12.2.2 Asia Tenofovir Disoproxil Fumarate Sales by Application (2021-2032)
  8. 12.2.3 Asia Tenofovir Disoproxil Fumarate Price by Application (2021-2032)
  9. 12.3 Asia Tenofovir Disoproxil Fumarate Market Size by Country
  10. 12.3.1 Asia Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Tenofovir Disoproxil Fumarate Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Tenofovir Disoproxil Fumarate Market Size by Type
  2. 13.1.1 SAMEA Tenofovir Disoproxil Fumarate Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Tenofovir Disoproxil Fumarate Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Tenofovir Disoproxil Fumarate Price by Type (2021-2032)
  5. 13.2 SAMEA Tenofovir Disoproxil Fumarate Market Size by Application
  6. 13.2.1 SAMEA Tenofovir Disoproxil Fumarate Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Tenofovir Disoproxil Fumarate Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Tenofovir Disoproxil Fumarate Price by Application (2021-2032)
  9. 13.3 SAMEA Tenofovir Disoproxil Fumarate Market Size by Country
  10. 13.3.1 SAMEA Tenofovir Disoproxil Fumarate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Tenofovir Disoproxil Fumarate Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Tenofovir Disoproxil Fumarate Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Tenofovir Disoproxil Fumarate Value Chain Analysis
  2. 14.1.1 Tenofovir Disoproxil Fumarate Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Tenofovir Disoproxil Fumarate Production Mode & Process
  6. 14.2 Tenofovir Disoproxil Fumarate Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Tenofovir Disoproxil Fumarate Distributors
  9. 14.2.3 Tenofovir Disoproxil Fumarate Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst